Experimental Study Highlights Potential Benefit of Zinc for Treating Vulvovaginal Candidiasis
Photo by Wengang Zhai on Unsplash

Experimental Study Highlights Potential Benefit of Zinc for Treating Vulvovaginal Candidiasis

  An estimated 75% of women will develop vulvovaginal candidiasis (a vaginal yeast infection) during their lifetime, with a significant number (approximately 140 million women worldwide) experiencing recurrent yeast infections.…

Continue Reading Experimental Study Highlights Potential Benefit of Zinc for Treating Vulvovaginal Candidiasis
Updated Phase 1/2 Data Highlights Vepdegestrant Benefits for ER+ HER2- Breast Cancer
Source: Pixabay

Updated Phase 1/2 Data Highlights Vepdegestrant Benefits for ER+ HER2- Breast Cancer

  A Phase 1/2 clinical trial sought to evaluate the potential of vepdegestrant as a therapeutic option for heavily pretreated individuals with estrogen receptor-positive (ER+) and HER2 negative (HER2-) advanced…

Continue Reading Updated Phase 1/2 Data Highlights Vepdegestrant Benefits for ER+ HER2- Breast Cancer
Rare Classroom: Sarcoidosis
source: shutterstock

Rare Classroom: Sarcoidosis

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most…

Continue Reading Rare Classroom: Sarcoidosis